Efor successfully completes a €300m refinancing to support its international growth strategy

Efor Group, a global leader in Quality & Compliance for Life Sciences, announces the successful completion of the refinancing of its existing debt for an amount of approximately €300 million.

This strategic transaction consists of:

• a €230 million senior Term Loan B,
• complemented by a €50 million super senior revolving credit facility.

The new financing structure replaces the existing unitranche debt and significantly reduces the Group’s cost of debt, while providing enhanced contractual flexibility fully aligned with its long-term development strategy.

Strong confidence from the financial community

The refinancing was completed with the support of a diversified pool of nearly 20 French and international banks and debt funds, demonstrating the attractiveness of Efor’s business model and the strength of its growth trajectory.

Lenders were particularly attracted by:

• Efor’s unique positioning as the only global player operating at scale in Commissioning, Qualification & Validation (CQV) and Quality Assurance (QA)
• The Group’s exposure to a resilient, non-discretionary and structurally growing Life Sciences market
• A strong growth track record, marked by a doubling in size over the past two years
• A proven ability to integrate acquisitions and expand geographically, particularly in North America and Asia
• The commitment and execution discipline of the management team led by Mathieu Roger

Entering the next phase of development

This transaction provides Efor with the financial strength and long-term visibility required to accelerate the next phase of its development.

The Group’s strategic priorities include:

• Accelerating international expansion
• Sustaining strong organic growth
• Executing targeted acquisitions
• Reinforcing its global leadership in Quality & Compliance services

North America and Asia remain key focus areas for the coming years.

A collective achievement

Efor was advised by Amala Partners as exclusive financial advisor on the financing. The Group also extends its sincere thanks to Bain & Company, Eight Advisory, Mayer Brown and Agilis for their rigorous and strategic support throughout the process.

Efor further expresses its gratitude to Raise Invest, Andera Partners and CAPZA — a long-standing partner since 2019 — as well as CIC Private Debt, Crescent Capital and all financial partners involved in this transaction.

With this refinancing, Efor strengthens its financial structure and reaffirms its ambition to build a global leader in Life Sciences compliance engineering.